An Act To Clarify And Increase Access To Hiv Prevention Medications

This bill requires MaineCare to reimburse pharmacists for prescribing, dispensing, and administering HIV prevention drugs (like PrEP) at the same rate paid to physicians, starting January 1, 2027. It mandates that insurance carriers cover at least one approved HIV prevention drug per administration method (e.g., oral pills or long-acting injections) without prior authorization or out-of-pocket costs. Pharmacists must follow specific protocols, including verifying a recent negative HIV test and providing counseling, before dispensing these drugs. The law directly affects pharmacists, MaineCare enrollees, and insurance carriers by expanding access to HIV prevention services and clarifying coverage requirements.